Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam Trial

Clinical trial NCT06671912 · SUSPENDED

Trial details

NCT number: NCT06671912
Sponsor: Alliance for Clinical Trials in Oncology
Status: SUSPENDED
Phase: Phase 3
Study type: INTERVENTIONAL

Anatomic Stage 0 Breast Cancer AJCC v8 Anatomic Stage 1 Breast Cancer AJCC v8 Anatomic Stage IIA Breast Cancer AJCC v8 Estrogen Receptor-Positive Breast Carcinoma HER2-Negative Breast Carcinoma Breast Ductal Carcinoma In Situ Breast Lobular Carcinoma In Situ

Start date: 2025-02-19
Primary completion: 2030-11-30
Enrollment: 1556

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.